Publications by authors named "Philip Drew"

Claim this Profile
P
PretoxTM: a text mining system for extracting treatment-related findings from preclinical toxicology reports.
Javier Corvi, Nicolás Díaz-Roussel, José M Fernández, Francesco Ronzano, Emilio Centeno, Philip Drew

J Cheminform· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
eTRANSAFE: data science to empower translational safety assessment.
Ferran Sanz, François Pognan, Thomas Steger-Hartmann, Carlos Díaz, Shoji Asakura, Philip Drew, Andrew R Leach

Nat Rev Drug Discov· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The eTRANSAFE Project on Translational Safety Assessment through Integrative Knowledge Management: Achievements and Perspectives.
François Pognan, Thomas Steger-Hartmann, Carlos Díaz, Niklas Blomberg, Frank Bringezu, Philip Drew, William C Drewe

Pharmaceuticals (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graphical display of histopathology data from toxicology studies for drug discovery and development: An industry perspective.
Alan P Brown, Philip Drew, Brian Knight, Philippe Marc, Sean Troth

Regul Toxicol Pharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Can Physical Activity Referral Rates for Breast Cancer Patients be Increased?
Martyn Queen, Christina Karatzaferi, Saul R Bloxham, Udaiveer Panwar, Philip Drew, Andrew G Barton, Andrew M Edwards

Front Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Antagonism of Human CD40 Achieved by Targeting a Unique Species-Specific Epitope.
Aaron P Yamniuk, Anish Suri, Stanley R Krystek, James Tamura, Vidhyashankar Ramamurthy, Philip Drew

J Mol Biol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response to primary letrozole therapy in elderly patients with early breast cancer: possible role for p53 as a biomarker.
Veerabhadram Garimella, Tasadooq Hussain, Vijay Agarwal, Selvi Radhakrishna, John N Fox, Philip J Drew

Int J Surg· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for complications following breast reduction: results from a randomized control trial.
Narasimhaiah Srinivasaiah, Obi C Iwuchukwu, Paul R W Stanley, Nicholas B Hart, Alastair J Platt, Philip J Drew

Breast J· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases.
Jenny H Xie, Aaron P Yamniuk, Virna Borowski, Robert Kuhn, Vojkan Susulic, Philip Drew

J Immunol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial.
Michael Douek, Joost Klaase, Ian Monypenny, Ashutosh Kothari, Katalin Zechmeister, Philip Drew

Ann Surg Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI guidelines: what a surgeon needs to know.
Philip J Drew

Eur J Radiol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancer.
Victoria C Hodgkinson, Vijay Agarwal, Dalia ELFadl, John N Fox, Penelope L McManus, Philip J Drew

J Proteomics· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic identification of predictive biomarkers of resistance to neoadjuvant chemotherapy in luminal breast cancer: a possible role for 14-3-3 theta/tau and tBID?
Victoria C Hodgkinson, Dalia ELFadl, Vijay Agarwal, Veerabhadram Garimella, Charlotte Russell, Philip J Drew

J Proteomics· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancer.
Dalia Elfadl, Victoria C Hodgkinson, Ervine D Long, Lucy Scaife, Philip J Drew

Breast· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential proteomics in the search for biomarkers of radiotherapy resistance.
Lucy Scaife, Victoria C Hodgkinson, Philip J Drew, Michael J Lind, Lynn Cawkwell

Expert Rev Proteomics· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysis.
Victoria C Hodgkinson, Dalia ElFadl, Philip J Drew, Michael J Lind, Lynn Cawkwell

J Proteomics· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.
Victoria C Hodgkinson, Gina L Eagle, Philip J Drew, Michael J Lind, Lynn Cawkwell

Cancer Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life issues in aesthetic breast surgery.
Narasimhaiah Srinivasaiah, Philip J Drew, Alastair Platt

Br J Hosp Med (Lond)· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome?
Laura Smith, Omar Qutob, Mark B Watson, Andrew W Beavis, Donna Potts, Philip J Drew

Neoplasia· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risks from heavy metal music. 'Mosh pit' breast?
Philip J Drew

BMJ· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proteomic analysis of cisplatin resistance in breast cancer cells.
Laura Smith, Kevin J Welham, Mark B Watson, Philip J Drew, Michael J Lind

Oncol Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The quality of trials in operative surgery.
Catherine J Walter, Jo C Dumville, Catherine E Hewitt, Katie C Moore, David J Torgerson, Philip J Drew

Ann Surg· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The putative roles of the ubiquitin/proteasome pathway in resistance to anticancer therapy.
Laura Smith, Michael J Lind, Philip J Drew, Lynn Cawkwell

Eur J Cancer· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgery is associated with lower morbidity and longer survival in elderly breast cancer patients over 80.
Vittal Sree Rama Rao, Jainudeen K A Jameel, Tapan K Mahapatra, Penelope L McManus, John N Fox, Philip J Drew

Breast J· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost of wound care for a local population in England.
Philip Drew, John Posnett, Louise Rusling,

Int Wound J· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis